Oops! … Stryker Did it Again

Stryker has signed an agreement to acquire Vertos Medical, a developer of a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.

Both companies will continue to operate as separate entities and proceed with business as usual until the transaction closes.

Vertos is known for the mild procedure. The company’s website states that mild is a “safe and minimally invasive outpatient procedure designed to restore space in the spinal canal through an incision smaller than the size of a baby aspirin.”

“We are committed to helping customers restore patients’ quality of life with interventional solutions to address chronic pain,” said Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker. “This acquisition strengthens our minimally invasive pain management portfolio with differentiated treatments and expands our reach across ambulatory surgery centers.”

“Allowing patients to get back to what matters most to them is what matters most to us,” said Eric Wichems, Vertos Medical’s Chief Executive Officer. “Stryker’s mission and focus on interventional solutions provides an opportunity to further improve patients' quality of life.”

Vertos Medical is the second acquisition the Kalamazoo, MI-based Stryker announced this month. Nearly two weeks ago, the firm reported that it would acquire Care.ai, a company specializing in artificial intelligence solutions for hospital settings.  

Related:Stryker Fires Up the M&A Engine Again

Stryker’s CEO Kevin Lobo mentioned in late July, that the company would be very active in M&A for the second half of 2024.